Results 171 to 180 of about 5,260,709 (398)
Steroyl-CoA Desaturase 1 (SCD1) protects ovarian cancer cells from ferroptotic cell death.
Cancer Research, 2019 Activation of ferroptosis, a recently described mechanism of regulated cell death, dramatically inhibits growth of ovarian cancer cells. Given the importance of lipid metabolism in ferroptosis and the key role of lipids in ovarian cancer, we examined the
L. Tesfay +9 more
semanticscholar +1 more source
Validation of a Multivariate Serum Profile for Epithelial Ovarian Cancer Using a Prospective Multi-Site Collection [PDF]
, 2010 In previous studies we described the use of a retrospective collection of ovarian cancer and benign disease samples, in combination with a large set of multiplexed immunoassays and a multivariate pattern recognition algorithm, to develop an 11-biomarker ...
Beth Y. Karlan +20 more
core +1 more source
Multimodal Magnetic Resonance and Near-Infrared-Fluorescent Imaging of Intraperitoneal Ovarian Cancer Using a Dual-Mode-Dual-Gadolinium Liposomal Contrast Agent. [PDF]
, 2016 The degree of tumor removal at surgery is a major factor in predicting outcome for ovarian cancer. A single multimodality agent that can be used with magnetic resonance (MR) for staging and pre-surgical planning, and with optical imaging to aid surgical ...
Annapragada, A +7 more
core +2 more sources
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
New England Journal of Medicine, 2003 BACKGROUND Although tumor-infiltrating T cells have been documented in ovarian carcinoma, a clear association with clinical outcome has not been established.
Lin Zhang +11 more
semanticscholar +1 more source
RhoA and Rac1 as Mechanotransduction Mediators in Colorectal Cancer
Advanced Biology, EarlyView.Analysing RhoA and Rac1 protein levels in Colorectal cancer (CRC) samples under mechanical strain highlights their potential as diagnostic markers. Monitoring their activity could offer valuable insights into how cancer spreads, paving the way for new approaches to better understand and diagnose colorectal cancer.
Sharda Yadav +5 more
wiley +1 more source
A Competing Risks Model with Binary Time Varying Covariates for Estimation of Breast Cancer Risks in BRCA1 Families [PDF]
arXiv, 2020 Mammographic screening and prophylactic surgery such as risk-reducing salpingo oophorectomy (RRSO) can potentially reduce breast cancer risks among mutation carriers of BRCA families. The evaluation of these interventions is usually complicated by the fact that their effects on breast cancer may change over time and by the presence of competing risks ...
arxiv
Journal of Clinical Oncology, 2019 PURPOSE Genetic testing for cancer risk has expanded rapidly. We examined clinical genetic testing and results among population-based patients with breast and ovarian cancer.
A. Kurian +8 more
semanticscholar +1 more source
The management of ovarian cancer
Annals of Oncology, 1993 A 52-year-old, postmenopausal woman presented to her gynecologist in October 1986 with fatigue, abdominal distention and intermittent vaginal bleeding. Pelvic examination revealed a right adnexal mass. She had no relevant medical history. After a minimal staging, including routine blood tests and a chest x-ray, she underwent an exploratory laparotomy ...
Prové, Annemie +3 more
openaire +4 more sources
Advanced Biology, EarlyView.The manuscript examines preclinical murine and human models to study polycystic ovary syndrome (PCOS), delving into the cellular and molecular mechanisms underlying altered ovarian follicular dynamics. It explores the cellular interactions involved in normal and PCOS ovaries and outlines the current and novel strategies in the search for preclinical ...
Arturo Bevilacqua +5 more
wiley +1 more source
The role of lymphography in patients with ovarian cancer [PDF]
, 1974 Bruce R. Parker +3 more
openalex +1 more source